SS-31: The Peptide ‘Mitochondrial Shield’ That May Block Parkinson’s Damage at the Source

About this episode

Dr. Mike discusses the peptide SS-31 and its potential protective effects against Parkinson's disease.

This is the first dedicated peptide deep dive of The Energy Code — and it starts with arguably the most mitochondrial-centric peptide on the board: SS-31 (Elamipretide). Dr. Mike breaks down a new paper showing how SS-31 may protect neurons in Parkinson’s disease by competing with alpha-synuclein at lipid membranes, slowing toxic aggregation, restoring mitochondrial respiration, and even reducing alpha-synuclein cellular entry. You’ll also hear a key caution: SS-31 appears highly protective at moderate doses, but too much may flip the benefit into harm, reinforcing the “dose makes the medicine” rule in mitochondrial pharmacology. (Educational content only, not medical advice.) - Article Discussed in Episode: Therapeutic Peptide SS-31 Modulates Membrane Binding and Aggregation of α-Synuclein and Restores Impaired Mitochondrial Function - Key Quotes From Dr. Mike: “The future of Parkinson’s therapy may not lie in cleaning up the mess, but rather in providing our neurons with a permanent molecular shield…” “SS-31 acts as a molecular shield protecting the brain’s energy supply…” “SS-31 acts as a molecular bouncer, physically evicting alpha-synuclein from lipid membranes…” “SS-31…

People in this episode

Host: Dr. Mike Belkowski

Topics covered

• peptides
• mitochondrial function
• Parkinson's disease
• neuroprotection
• alpha-synuclein
• pharmacology

Keywords

• SS-31
• Elamipretide
• mitochondrial shield
• alpha-synuclein
• neuroprotection
• Parkinson's therapy
• dose response

Mentioned in this episode

Products: SS-31

Books & works: Therapeutic Peptide SS-31 Modulates Membrane Binding and Aggregation of α-Synuclein and Restores Impaired Mitochondrial Function

More episodes of The Energy Code

• The Energy Code Blueprint: Longevity Starts in the Mitochondria, Pt. 2 · June 11, 2026 · 58 min
• MOTS-c: The ‘Exercise Mimetic’ Peptide That Rewires Metabolism, Fat Loss, and Mitochondrial Resilience · June 8, 2026 · 31 min
• The Energy Code Blueprint: Longevity Starts in the Mitochondria, Pt. 1 · June 4, 2026 · 1h 2m
• Mitoredox: The “Electron Flow” Master Switch Behind Aging, Disease, and Mitochondrial Collapse · June 3, 2026 · 21 min
• The “Missing Peptides” Behind AFib: Humanin + MOTS-c and the Fibrosis Switch · June 2, 2026 · 15 min
• MitoQ, SS-31, Mitophagy, and Mito-Transplants: The Future of SCI Repair · May 28, 2026 · 23 min